Less invasive endovascular aneurysm repair (EVAR) offers an improved survival benefit for patients with ruptured abdominal aortic aneurysms compared with surgical repair, according to study results presented Jan. 22 at the International Symposium on Endovascular Therapy (ISET) in Miami Beach, Fla. But long-term mortality remained high in both groups.

The U.K.’s National Institute of Health and Clinical Excellence (NICE) has recommended apixaban in its final draft guidance for the prevention of stroke and systemic embolism in some people with nonvalvular atrial fibrillation (AF).

Within the PCI and CABG arms of the All-Comers SYNTAX trial, incomplete revascularization that is angiographically determined has a detrimental impact on long-term clinical outcomes, including mortality. This effect remained consistent in patients with and without total occlusions, according to the study authors.

The American College of Cardiology (ACC) has released its lineup of late-breaking clinical trials that will be featured at its 2013 annual scientific meeting, March 9 through 11 in San Francisco. Cardiovascular Business will be there to bring you daily coverage of the presentations.

St. Jude Medical has reported a drop in sales and net earnings for the fourth quarter and year, which ended Dec. 29, 2012. However, the company saw a bump in atrial fibrillation product sales during these time periods.

Covidien has received CE Mark approval for its EverFlex self-expanding peripheral stent with Entrust delivery system.

The European Commission has granted marketing authorizations for insulin degludec (Tresiba) and insulin degludec/insulin aspart (Ryzodeg), both marketed by Novo Nordisk, for the treatment of diabetes in adults.

The results of a Phase II trial exploring the efficacy of combination treatment in dissolving deep venous thromboli (DVT) suggest that the procedure resolves DVT so quickly that treatment may someday be handled on an outpatient basis, Robert A. Lookstein, MD, told Cardiovascular Business. He presented the results Jan. 21 at the International Symposium on Endovascular Therapy (ISET) in Miami Beach, Fla.